Cibc World Markets Corp acquired a new stake in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC.

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...

Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly ...

Overview. The National Cancer Center (President: Hitoshi Nakagama, hereinafter "NCC") Hospital East (Director: Toshihiko Doi), The Nati ...

The FDA has approved Gvoke VialDx (glucagon) for IV use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the GI tract.